Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03)

Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03) is a phase 3, randomised interventional study registered as NCT05909332 by Fudan University, with a registry enrolment figure of 764 participants, started 2023-06-20 and due to reach its primary completion in 2029-05-30. Interventions recorded: Antivascular therapy; Chemotherapy. Conditions listed: Breast Cancer; Triple Negative Breast Cancer. Triple-negative eligibility wording from the registry: "* Histological results recorded as TNBC (negative HER2, ER, and PgR status) and BLIS subtype according to the classification of FUSCC;". Sites: China. No results are recorded here; the registry entry is the source.